{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:58:34Z","timestamp":1791176314561,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T00:00:00Z","timestamp":1639526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T00:00:00Z","timestamp":1639526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Our aim was to construct and test an intervention programme to eradicate cough and cold medicine (CCM) prescriptions for children treated in a nationwide healthcare service company. The study was carried out in the largest private healthcare service company in Finland with a centralised electronic health record system allowing for real-time, doctor-specific practice monitoring. The step-by-step intervention consisted of company-level dissemination of educational materials to doctors and families, educational staff meetings, continuous monitoring of prescriptions, and targeted feedback. Outreach visits were held in noncompliant units. Finally, those physicians who most often prescribed CCM were directly contacted. During the intervention period (2017\u20132020), there were more than one million paediatric visits. Prescriptions of CCMs to children were completely eradicated in 41% of units and the total number of CCM prescriptions decreased from 6738 to 744 (89%). During the fourth intervention year, CCMs containing opioid derivatives were prescribed for only 0.2% of children aged\u2009&lt;\u20092\u00a0years. The decrease in prescriptions was greatest in general practitioners (5.2 to 1.1%). In paediatricians, the prescription rates decreased from 1.5 to 0.2%. The annual costs of CCMs decreased from \u20ac183,996 to \u20ac18,899 (89.7%). For the intervention, the developers used 343\u00a0h and the attended doctors used 684\u00a0h of work time during the 4-year intervention. The costs used for developing, implementing, reporting, evaluating, communicating, and data managing formed approximately 11% of total intervention costs.<\/jats:p><jats:p><jats:italic>Conclusion<\/jats:italic>: The study showed that a nationwide systematic intervention to change cough medicine prescription practices is feasible and requires only modest financial investments.<jats:table-wrap><jats:table><jats:tbody>\n                    <jats:tr>\n                      <jats:td colspan=\"2\"><jats:bold>What is Known:<\/jats:bold><jats:italic>\u2022 Cough and cold medicines (CCM) are not effective or safe, especially for children aged 6 years.<\/jats:italic><jats:italic>\u2022 Although the use of CCMs has been declining, caregivers continue to administer CCMs to children, and some physicians still prescribe them even for preschool children.<\/jats:italic><\/jats:td>\n                    <\/jats:tr>\n                    <jats:tr>\n                      <jats:td colspan=\"2\"><jats:bold>What is New:<\/jats:bold><jats:italic>\u2022 A nationwide systematic intervention can significantly and cost effectively change CCM prescription habits of paediatricians, general practitioners, and other specialists.<\/jats:italic><jats:italic>\u2022 Electronic health records provide additional tools for operative guideline implementation and real-time quality monitoring, including recommendations of useless or harmful treatments.<\/jats:italic><\/jats:td>\n                    <\/jats:tr>\n                  <\/jats:tbody><\/jats:table><\/jats:table-wrap><\/jats:p>","DOI":"10.1007\/s00431-021-04344-0","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T22:03:40Z","timestamp":1639605820000},"page":"1531-1539","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cough and cold medicine prescription rates can be significantly reduced by active intervention"],"prefix":"10.1007","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0819-7875","authenticated-orcid":false,"given":"P\u00e9ter","family":"Csonka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Heikkil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Koskela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sauli","family":"Palmu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noora","family":"Lajunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Riihij\u00e4rvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heini","family":"Huhtala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Korppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,15]]},"reference":[{"key":"4344_CR1","doi-asserted-by":"publisher","first-page":"f7027","DOI":"10.1136\/bmj.f7027","volume":"347","author":"M Thompson","year":"2013","unstructured":"Thompson M, Vodicka TA, Blair PS et al (2013) Duration of symptoms of respiratory tract infections in children: systematic review. BMJ 347:f7027\u2013f7027. https:\/\/doi.org\/10.1136\/bmj.f7027","journal-title":"BMJ"},{"key":"4344_CR2","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1164\/ajrccm.155.6.9196099","volume":"155","author":"AB Chang","year":"1997","unstructured":"Chang AB, Phelan PD, Sawyer SM, Robertson CF (1997) Airway hyperresponsiveness and cough-receptor sensitivity in children with recurrent cough. Am J Respir Crit Care Med 155:1935\u20131939. https:\/\/doi.org\/10.1164\/ajrccm.155.6.9196099","journal-title":"Am J Respir Crit Care Med"},{"key":"4344_CR3","unstructured":"American Academy of Pediatrics (2013) Cough and cold medicines should not be prescribed, recommended or used for respiratory illnesses in young children. https:\/\/www.choosingwisely.org\/clinician-lists\/american-academy-pediatrics-cough-and-cold-medicines-for-children-under-four\/. Accessed 7 Apr 2021"},{"key":"4344_CR4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/jamapediatrics.2019.2252","volume":"173","author":"DB Horton","year":"2019","unstructured":"Horton DB, Gerhard T, Strom BL (2019) Trends in cough and cold medicine recommendations for children in the United States, 2002\u20132015. JAMA Pediatr 173:885. https:\/\/doi.org\/10.1001\/jamapediatrics.2019.2252","journal-title":"JAMA Pediatr"},{"key":"4344_CR5","unstructured":"US Food and Drug Administration (2018) Use caution when giving cough and cold products to kids. https:\/\/www.fda.gov\/drugs\/special-features\/use-caution-when-giving-cough-and-cold-products-kids. Accessed 26 Mar 2021"},{"key":"4344_CR6","unstructured":"Health Canada (2008) Health Canada releases decision on the labelling of cough and cold products for children. https:\/\/www.healthycanadians.gc.ca\/recall-alert-rappel-avis\/hc-sc\/2008\/13267a-eng.php"},{"key":"4344_CR7","unstructured":"US Food and Drug Administration (2018) FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-requires-labeling-changes-prescription-opioid-cough-and-cold. Accessed 7 Apr 2021"},{"key":"4344_CR8","unstructured":"European Medicines Agency (2015) Codeine-containing medicinal products for the treatment of cough or cold in paediatric patients. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/codeine-containing-medicinal-products-treatment-cough-cold-paediatric-patients#overview-section. Accessed 28 Mar 2021"},{"key":"4344_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001831.pub5.www.cochranelibrary.com","author":"S Smith","year":"2014","unstructured":"Smith S, Schroeder K, Fahey T (2014) Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD001831.pub5.www.cochranelibrary.com","journal-title":"Cochrane Database Syst Rev"},{"key":"4344_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011914.pub2.www.cochranelibrary.com","author":"S Gardiner","year":"2016","unstructured":"Gardiner S, Chang A, Marchant J, Petsky H (2016) Codeine versus placebo for chronic cough in children (Review). Cochrane Database ofSystematic Rev. https:\/\/doi.org\/10.1002\/14651858.CD011914.pub2.www.cochranelibrary.com","journal-title":"Cochrane Database ofSystematic Rev"},{"key":"4344_CR11","doi-asserted-by":"publisher","first-page":"1901136","DOI":"10.1183\/13993003.01136-2019","volume":"55","author":"AH Morice","year":"2020","unstructured":"Morice AH, Millqvist E, Bieksiene K et al (2020) ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 55:1901136. https:\/\/doi.org\/10.1183\/13993003.01136-2019","journal-title":"Eur Respir J"},{"key":"4344_CR12","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1542\/peds.2013-2236","volume":"132","author":"LM Hampton","year":"2013","unstructured":"Hampton LM, Nguyen DB, Edwards JR, Budnitz DS (2013) Cough and cold medication adverse events after market withdrawal and labeling revision. Pediatrics 132:1047\u20131054. https:\/\/doi.org\/10.1542\/peds.2013-2236","journal-title":"Pediatrics"},{"key":"4344_CR13","doi-asserted-by":"publisher","first-page":"e1139","DOI":"10.1542\/peds.2013-3171","volume":"133","author":"SV Kaiser","year":"2014","unstructured":"Kaiser SV, Asteria-Penaloza R, Vittinghoff E et al (2014) National patterns of codeine prescriptions for children in the emergency department. Pediatrics 133:e1139\u2013e1147. https:\/\/doi.org\/10.1542\/peds.2013-3171","journal-title":"Pediatrics"},{"key":"4344_CR14","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jpeds.2014.07.047","volume":"165","author":"M Mazer-Amirshahi","year":"2014","unstructured":"Mazer-Amirshahi M, Rasooly I, Brooks G et al (2014) The impact of pediatric labeling changes on prescribing patterns of cough and cold medications. J Pediatr 165:1024-1028.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2014.07.047","journal-title":"J Pediatr"},{"key":"4344_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1471-2296-14-106","volume":"14","author":"J Ingram","year":"2013","unstructured":"Ingram J, Cabral C, Hay AD et al (2013) Parents\u2019 information needs, self-efficacy and influences on consulting for childhood respiratory tract infections: a qualitative study. BMC Fam Pract 14:106. https:\/\/doi.org\/10.1186\/1471-2296-14-106","journal-title":"BMC Fam Pract"},{"key":"4344_CR16","doi-asserted-by":"publisher","unstructured":"Stockwell MS, Catallozzi M, Larson E et al (2014) Effect of a URI-related educational intervention in early head start on ED visits. Pediatrics 133. https:\/\/doi.org\/10.1542\/peds.2013-2350","DOI":"10.1542\/peds.2013-2350"},{"key":"4344_CR17","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S0140-6736(03)14546-1","volume":"362","author":"R Grol","year":"2003","unstructured":"Grol R, Grimshaw J (2003) From best evidence to best practice: effective implementation of change in patients\u2019 care. Lancet 362:1225\u20131230. https:\/\/doi.org\/10.1016\/S0140-6736(03)14546-1","journal-title":"Lancet"},{"key":"4344_CR18","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","volume":"282","author":"MD Cabana","year":"1999","unstructured":"Cabana MD, Rand CS, Powe NR et al (1999) Why don\u2019t physicians follow clinical practice guidelines? A framework for improvement. JAMA 282:1458\u20131465. https:\/\/doi.org\/10.1001\/jama.282.15.1458","journal-title":"JAMA"},{"key":"4344_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1748-5908-4-54","volume":"4","author":"M Lugtenberg","year":"2009","unstructured":"Lugtenberg M, Zegers-van Schaick JM, Westert GP, Burgers JS (2009) Why don\u2019t physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners. Implement Sci 4:54. https:\/\/doi.org\/10.1186\/1748-5908-4-54","journal-title":"Implement Sci"},{"key":"4344_CR20","unstructured":"The Finnish Medical Society Duodecim and the FPS and the FS of GMHTFMS (2014) Lower respiratory tract infections (children). Current Care Guidelines. In: Duodecim. www.kaypahoito.fi. Accessed 26 Mar 2021"},{"key":"4344_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/apa.15829","author":"JE Kivist\u00f6","year":"2021","unstructured":"Kivist\u00f6 JE, Poutanen R, Protudjer JLP et al (2021) Current Care Guidelines had no immediate effects on antitussive prescriptions to Finnish children. Acta Paediatr. https:\/\/doi.org\/10.1111\/apa.15829","journal-title":"Acta Paediatr"},{"key":"4344_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/pgmj.72.843.19","volume":"72","author":"D Forrest","year":"1996","unstructured":"Forrest D, Hoskins A, Hussey R (1996) Clinical guidelines and their implementation. Postgrad Med J 72:19\u201322. https:\/\/doi.org\/10.1136\/pgmj.72.843.19","journal-title":"Postgrad Med J"},{"key":"4344_CR23","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1111\/apa.14397","volume":"107","author":"S Palmu","year":"2018","unstructured":"Palmu S, Mecklin M, Heikkil\u00e4 P et al (2018) National treatment guidelines decreased the use of racemic adrenaline for bronchiolitis in four Finnish university hospitals. Acta Paediatr 107:1966\u20131970. https:\/\/doi.org\/10.1111\/apa.14397","journal-title":"Acta Paediatr"},{"key":"4344_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2021.0295","author":"L Haskell","year":"2021","unstructured":"Haskell L, Tavender EJ, Wilson CL et al (2021) Effectiveness of targeted interventions on treatment of infants with bronchiolitis. JAMA Pediatr. https:\/\/doi.org\/10.1001\/jamapediatrics.2021.0295","journal-title":"JAMA Pediatr"},{"key":"4344_CR25","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1177\/0009922820928054","volume":"59","author":"MCG Diaz","year":"2020","unstructured":"Diaz MCG, Handy LK, Crutchfield JH et al (2020) Impact of a personalized audit and feedback intervention on antibiotic prescribing practices for outpatient pediatric community-acquired pneumonia. Clin Pediatr (Phila) 59:988\u2013994. https:\/\/doi.org\/10.1177\/0009922820928054","journal-title":"Clin Pediatr (Phila)"},{"key":"4344_CR26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jpainsymman.2011.01.008","volume":"42","author":"G Rosenbluth","year":"2011","unstructured":"Rosenbluth G, Wilson SD, Maselli JH, Auerbach AD (2011) Analgesic prescribing practices can be improved by low-cost point-of-care decision support. J Pain Symptom Manage 42:623\u2013631. https:\/\/doi.org\/10.1016\/j.jpainsymman.2011.01.008","journal-title":"J Pain Symptom Manage"},{"key":"4344_CR27","doi-asserted-by":"publisher","unstructured":"Akenroye AT, Baskin MN, Samnaliev M, Stack AM (2014) Impact of a bronchiolitis guideline on ED resource use and cost: a segmented time-series analysis. Pediatrics 133. https:\/\/doi.org\/10.1542\/peds.2013-1991","DOI":"10.1542\/peds.2013-1991"},{"key":"4344_CR28","doi-asserted-by":"publisher","unstructured":"Bryan\u00a0MA, Desai AD, Wilson\u00a0L et al (2017) Association of bronchiolitis clinical pathway adherence with length of stay and costs Pediatrics 139.\u00a0https:\/\/doi.org\/10.1542\/peds.2016-3432","DOI":"10.1542\/peds.2016-3432"},{"key":"4344_CR29","doi-asserted-by":"publisher","first-page":"E423","DOI":"10.1097\/INF.0000000000002845","volume":"39","author":"I Kuitunen","year":"2020","unstructured":"Kuitunen I, Artama M, M\u00e4kel\u00e4 L et al (2020) Effect of social distancing due to the COVID-19 pandemic on the incidence of viral respiratory tract infections in children in Finland during early 2020. Pediatr Infect Dis J 39:E423\u2013E427. https:\/\/doi.org\/10.1097\/INF.0000000000002845","journal-title":"Pediatr Infect Dis J"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-04344-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-021-04344-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-04344-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T13:14:05Z","timestamp":1648559645000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-021-04344-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,15]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["4344"],"URL":"https:\/\/doi.org\/10.1007\/s00431-021-04344-0","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,15]]},"assertion":[{"value":"23 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was a quality assessment and development project. All data was coded, and patients were not contacted. According to the Finnish law, approval from the ethics committee was not required. This study was approved by the chief medical officer of Terveystalo.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"N\/A","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PC, SK, NL, and SR are employees of Terveystalo. The other authors declare no competing of interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}